首页
>>
产品中心
>>
抗体产品
>>
重组抗体
>
Anti-Human CD248 Recombinant Antibody

Anti-Human CD248 Recombinant Antibody

产品编号

YR1332

别名

科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab

规格
  • 1mg
  • 5mg
产品介绍
Catalog NumberYR1332
Alias科研级 Ontuxizumab ( 昂妥昔珠单抗 ), Anti-CD248 Recombinant Antibody, Research Grade Ontuxizumab
Size1mg, 5mg
Molecular NameOntuxizumab
CAS Number946415-62-9
TargetCD248[Homo sapiens]
HostMouse
Antibody IsotypeIgG1 Kappa
ClonityMonoclonal
Concentration1mg/ml
Purity>95% as determined by SDS-PAGE
Storage ConditionIt is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
FormulationPBS, pH7.5
Shipping ConditionShipped on ice packs.
BackgroundOntuxizumab is a humanized rabbit monoclonal antibody designed for the treatment of cancer. It binds to endosialin (TEM1 or CD248). Phase I trials are complete and the drug was granted orphan drug status by the FDA for sarcoma. It is currently in phase II trials for melanoma, colorectal cancer, sarcoma, and lymphoma. This drug was developed by Morphotek and Ludwig Institute for Cancer Research.
ApplicationNeut, ELISA, IF, IP, FuncS, FCM, ICC
RemarksThis product is for research use only.

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价